Transmeta Corp (NASDAQ:TMTA.DL)
CAPS Rating:
The Company develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property.
The Company develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Nothing new here, coasting down on licensing fees that while substantial, will not keep the company ahead of it's once dynamic game. $21 per share in the bank and no debt woudld be a nice cushion for a company with only 35 full time employees, but the spike to it's 52 week high seems to have satisfied director Riley. He went buying below $13 through July, but has been selling nearly daily in November at $17. Doesn't seem impressed by the new attention the companies is getting. Ability to generate future cash flow, licensing that depends on volume that is weak right now, and no new "intellectual" property in the pipelline would make it seem that they are winding down shop. The question is will the $21 per share be a nice one time dividend that shareholders will get, or will it disappear into tiny bits.